🇺🇸 FDA
Patent

US 9101601

Methods of treating or preventing insulin resistance and associated diseases and conditions

granted A61KA61K31/343A61K31/352

Quick answer

US patent 9101601 (Methods of treating or preventing insulin resistance and associated diseases and conditions) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/343, A61K31/352, A61K31/381, A61K31/382